Qualisure Diagnostics Inc. develops molecular diagnostic tests that enhance cancer care through early detection, improving diagnostic precision, and facilitating individualization of treatments. Our biomarkers and algorithms are designed to make cancer screening easier and more convenient for the patient; to guide decision making for oncologists; and to drive cost savings for the healthcare system. Each of our biomarkers is designed to influence clinical decision making and to facilitate Precision Medicine.
View Top Employees from Qualisure Diagnostics Inc.Website | http://www.qualisuredx.com |
Revenue | $1 million |
Employees | 10 (7 on RocketReach) |
Founded | 2017 |
Address | 3553 31 St NW, Calgary, Alberta, CA |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology, Medical Testing & Clinical Laboratories, Decision/Risk Analysis, Healthcare, Outcome Management (Healthcare) |
Competitors | Biosystemix Ltd, Contextual Genomics, Nanostics Inc., Rna Diagnostics Inc. |
SIC | SIC Code 80 Companies, SIC Code 807 Companies |
NAICS | NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies |
Looking for a particular Qualisure Diagnostics Inc. employee's phone or email?
The Qualisure Diagnostics Inc. annual revenue was $1 million in 2024.
Dave Ehman is the CTO of Qualisure Diagnostics Inc..
7 people are employed at Qualisure Diagnostics Inc..
Qualisure Diagnostics Inc. is based in Calgary, Alberta.
The NAICS codes for Qualisure Diagnostics Inc. are [6215, 621, 62, 62151].
The SIC codes for Qualisure Diagnostics Inc. are [80, 807].